Aviado · Research
Longevity Daily
Sunday, May 31, 2026
Listen
Today's Brief
Today's digest centers on a powerful theme: how much of aging is actually within your control. A landmark twin study makes the case that 60% of biological aging is shaped by lifestyle, not genetics — making it today's must-read. Two findings challenge conventional wisdom: hormone therapy may not preserve cognition as widely assumed, and popular longevity protocols were mostly designed around male biology. Rounding out the issue: why afternoon naps may hurt the aging brain, ergothioneine as a rising supplement star, and Harvard's first public-facing longevity report.
10 stories6 peer-reviewed1 trials
Cognitive Health & Neuroprotection
Later Menopause Predicts Better Cognition — But Hormone Therapy Doesn't, Major Study Finds
A major longitudinal analysis of 10,978 postmenopausal women from the Canadian Longitudinal Study on Aging found that natural menopause timing — not hormone therapy — is the key predictor of late-life cognitive performance. Women who experienced menopause later showed significantly stronger cognitive trajectories, while a history of HT showed no general cognitive benefit. This is a direct challenge to the widely held assumption that hormone replacement protects brain health, and suggests that when you stop menstruating may matter more than what you take afterward.
Read more →Giving Up Afternoon Naps Protects the Aging Brain, 12-Month RCT Shows
A 12-month randomized controlled trial found that older adults who eliminated regular afternoon napping showed significantly better brain health outcomes than those who continued the habit. Regular daytime napping in older adults can fragment nighttime sleep and disrupt circadian rhythms, creating a feedback loop that accelerates cognitive decline. If you're over 60 and napping daily, this RCT offers the strongest evidence yet that breaking the habit could be protecting your brain.
Read more →Supplements & Compounds
Ergothioneine: The Mushroom Molecule Emerging as a Multi-Target Longevity Compound
Ergothioneine (ET), a sulfur-rich amino acid found abundantly in shiitake and other edible mushrooms, has spent over a century in relative obscurity — but new evidence is positioning it as one of the most promising multi-target geroprotectors available from food. Unlike conventional antioxidants, ET has its own dedicated cellular transporter (OCTN1) that actively concentrates it in high-demand tissues including the brain, liver, and mitochondria, suggesting the body treats it as essential. Emerging data shows ET acting on multiple aging hallmarks simultaneously — oxidative stress, inflammation, and mitochondrial dysfunction — making it a compound worth tracking.
Read more →Which Supplements Actually Slow Epigenetic Aging? A New Paper Scores the Evidence
A comprehensive new analysis reviewed which medicines, supplements, and lifestyle factors most reliably reduce biological age as measured by next-generation epigenetic clocks. This is the kind of systematic scoring longevity protocol designers have been waiting for — moving beyond anecdote to rank what actually shifts the needle on DNA methylation age. Coverage reportedly spans metformin, rapamycin, and a range of specific supplement classes, with direct implications for anyone building or refining a longevity stack.
Read more →Research & Papers
Twin Study: Biological Aging Is 60% Determined by Your Choices, Not Your Genes
A groundbreaking study tracking 12,256 twins used the MetaboHealth metabolomics clock — one of the most validated biological aging measures available — to determine how much of your aging rate is predetermined versus modifiable. The answer is striking: roughly 60% of the variation in MetaboHealth scores is explained by lifestyle and environment, not genetics, with even identical twins diverging meaningfully over time. This is among the strongest human evidence to date that biological aging is not a fixed destiny — your diet, exercise habits, and environment are actively steering your cellular aging trajectory. For anyone building a longevity protocol, this is the data behind the conviction.
Read more →Rapamycin, Metformin, and Most Longevity Protocols Were Never Tested on Women
An important investigation reveals a critical blind spot in longevity medicine: the human evidence behind popular protocols like rapamycin and metformin is almost entirely drawn from male subjects, leaving women navigating open questions about immune function, wound healing, and hormonal interactions. "The female-specific evidence is paper-thin," notes one expert — and as these compounds gain mainstream traction, the data gap is becoming harder to ignore. This is essential reading for any woman considering these protocols, or for clinicians advising them.
Read more →Women Live Longer but Suffer More: Lancet Study Reveals a Growing Healthspan Gap
A major Lancet study finds that while women outlive men globally, they spend significantly more of those extra years battling pain, depression, anxiety, and other disabling conditions — a healthspan gap that longevity research has largely overlooked. The findings suggest that lifespan and healthspan are being systematically decoupled in women, and that simply living longer is not the same as aging well. It's a call to action for longevity interventions specifically targeting the quality, not just the quantity, of women's later years.
Read more →The Thymus Is Back: Regrowing the Immune System's Forgotten Engine
The thymus — the small organ behind your sternum responsible for training T cells — begins shrinking after puberty and is largely replaced by fat by midlife, a process called thymic involution that may be one of the most underappreciated drivers of immune aging. New research is putting thymic rejuvenation at the center of longevity medicine, with emerging interventions from peptide therapies to targeted hormone protocols showing measurable thymic regrowth in early human data. Rebuilding this forgotten immune engine is increasingly viewed as essential infrastructure for healthspan extension.
Read more →Lifestyle & Nutrition
Why Hard Exercise Ages You Slower: The Exercise-Lactate Epigenetic Connection
New research identifies lactate — the molecule your muscles produce during vigorous exercise — as the key epigenetic signaling molecule that translates hard workouts into long-term, systemic anti-aging effects. The finding helps explain why high-intensity exercise appears disproportionately protective against aging: it's not just cardiovascular adaptation or calories burned, but the lactate-driven epigenetic reprogramming that follows. This gives a clear molecular rationale for prioritizing Zone 3–4 training in any longevity-focused exercise protocol.
Read more →Industry & Policy
Harvard Enters the Chat: New Public Longevity Report Signals a Mainstream Tipping Point
Harvard has released "Pathways to Longevity," a public-facing report introducing key longevity science concepts to a general audience — the first time an institution of this stature has published a consumer-facing explainer on the field. The report's mainstream framing signals that longevity research is crossing from niche biohacking territory into institutionally validated science. Expect this to accelerate research funding, regulatory dialogue, and broader public demand for longevity interventions.
Read more →